Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The pharmacokinetic properties of oral and intravenous artesunate (2 mg/kg of body weight) were studied in 19 adult patients with acute uncomplicated Plasmodium falciparum malaria by using a randomized crossover design. A sensitive bioassay was used to measure the antimalarial activity in plasma which results from artesunate and its principal metabolite, dihydroartemisinin. The oral study was repeated with 15 patients during convalescence. The mean absolute oral bioavailability of the antimalarial agent in patients with acute malaria was 61% (95% confidence interval [CI], 52 to 70%). The absorption and elimination of oral artesunate were rapid, with a mean elimination half-life of antimalarial activity of 43 min (95% CI, 33 to 53 min). Following oral administration to patients with acute falciparum malaria, peak antimalarial activity in plasma and the area under the plasma concentration-time curve were approximately double those during convalescence and the apparent volume of distribution and clearance were approximately half those during convalescence (P < or = 0.005). Acute malaria is associated with a significant reduction in the clearance of artesunate-associated antimalarial activity.

Original publication

DOI

10.1128/aac.44.4.972-977.2000

Type

Journal article

Journal

Antimicrob Agents Chemother

Publication Date

04/2000

Volume

44

Pages

972 - 977

Keywords

Administration, Oral, Adolescent, Adult, Antimalarials, Area Under Curve, Artemisinins, Artesunate, Biological Availability, Chromatography, High Pressure Liquid, Electrochemistry, Female, Half-Life, Humans, Injections, Intravenous, Intestinal Absorption, Malaria, Falciparum, Male, Models, Biological, Sesquiterpenes